TriangleCANCER EVIDENCE
Choose the population source.
Different releases and measures describe different populations. Keep their diagnosis periods, stage definitions and follow-up windows separate.
5-Year Survival
Relative survival five years after diagnosis.
70 source groups · 65,440 source series
Explore populations →Conditional Survival
Relative survival over the next five years, among people who have already survived to a stated point.
66 source groups · 255,360 source series
Explore populations →Recent Trends
How relative survival differs across recent diagnosis years.
61 source groups · 32,760 source series
Explore populations →Long-Term Trends
How relative survival differs across the longer diagnosis-year series.
33 source groups · 1,032 source series
Explore populations →Current follow-up
66 published source groups · 63,840 exact population curves
Open the current explorer →SEER Cancer Stat Facts
Source summaries, five-year figures, historical observations and available subtype data.
Read the captured sources →The four additional SEER collections preserve 354,592 source series and 1,021,576 points from the recovered package. Missing values remain missing. Diagnosis-period labels were not supplied in that package; no dates or estimates have been inferred. Independent clinical and statistical review is pending.
November 2024 follow-up archive
67 source groups · 65,040 archived curves. Use for source history, not as a substitute for the current release.
Acute Lymphocytic Leukemia (ALL)
Acute Monocytic Leukemia (AML-M5)
Acute Myeloid Leukemia (AML)
Adenocarcinoma of the Esophagus
Adenocarcinoma of the Lung and Bronchus
All Cancer Sites Combined
Anus, Anal Canal & Anorectum
Bones and Joints
Brain and Other Nervous System
Breast
Cervix Uteri
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloid Leukemia (CML)
Chronic Myelomonocytic Leukemia (CMML)
Chronic myeloproliferative disorders (CMD)
Colon and Rectum (excluding Appendix)
Colon and Rectum (including Appendix)
Colon (including Appendix)
Corpus and Uterus, NOS
Diffuse Astrocytoma and Anaplastic Astrocytoma of the Brain and ONS
Embryonal Tumors of the Brain and ONS
Esophagus
Eye and Orbit
Floor of Mouth
Follicular Subtype of the Thyroid
Gallbladder
Glioblastoma of the Brain and ONS
Gum & other mouth
Hodgkin Lymphoma
Kaposi Sarcoma
Kidney
Kidney and Renal Pelvis
Large Cell Carcinoma of the Lung and Bronchus
Larynx
Leukemia
Lip
Liver and Intrahepatic Bile Duct
Lung and Bronchus
Melanoma of the Skin
Meningioma of the Brain and ONS
Mesothelioma
Myelodysplastic syndromes (MDS)
Myeloma
Non-Hodgkin Lymphoma
Oral Cavity and Pharynx
Oropharynx & Tonsil
Other Glioma of the Brain and ONS
Other Tumors of Brain and ONS
Ovary
Pancreas
Papillary Subtype of the Thyroid
Prostate
Rectum
Renal Pelvis
Salivary Gland
Small cell carcinoma of the Lung and Bronchus
Small Intestine
Soft Tissue including Heart
Squamous Cell Carcinoma of the Esophagus
Squamous Cell Carcinoma of the Lung and Bronchus
Stomach
Testis
Thyroid
Tongue
Urinary Bladder (Invasive & In Situ)
Vagina
Vulva
Preserved source evidence · Independent clinical review pending · Not medical advice